Skip to search formSkip to main contentSkip to account menu

clofilium

Known as: Benzenebutanaminium, 4-Chloro-N,N-Diethyl-N-Heptyl, (4-(P-Chlorophenyl)Butyl)Diethylheptylammonium, Benzenebutanaminium, 4-chloro-N,N-diethyl-N-heptyl- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
This study was designed to compare the proarrhythmic activity of the antimalarial drug, halofantrine and the antihistamine… 
Highly Cited
2002
Highly Cited
2002
Exposure to reactive oxygen species (ROS) is associated with tissue damage in the lung and may be a common element in the… 
Review
2001
1998
1998
AbstractObjective: The clinical usefulness of class III antiarrhythmic drugs for the treatment of tachyarrhythmias is limited by… 
Highly Cited
1993
Highly Cited
1993
Summary Class III agents have been associated with development of a polymorphic ventricular tachycardia (PVT) known as torsades… 
1991
1991
The effect of long-term oral administration of antiarrhythmic drugs on defibrillation energy requirements is not well understood… 
Highly Cited
1991
Highly Cited
1991
Neonatal mouse cardiac poly(A)+ mRNA microinjection into Xenopus oocytes directed the expression of a delayed rectifier K… 
1991
1991
Sematilide (N-[2-(diethylamino)ethyl]-4-[(methylsulfonyl)amino]benzamide HCl) is a new class III antiarrhythmic agent that has… 
1984
1984
Clofilium, a new quaternary ammonium antiarrhythmic without apparent ganglion‐blocking effect, was evaluated in 25 patients, 22…